InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the full record of transactions filed by Rodman David Malcom, Chief Medical Officer. Insider active across 1 companies, notably Mineralys Therapeutics, Inc.. In total, 16 disclosures have been recorded. Total volume traded: €1.3m. The latest transaction was disclosed on 11 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations16 total
US$29,4872,171 shares@ US$13.58240.0013% mcap3.8% of flow
Common Stock
SEC:0001672659-26-000027·
€29,4872,171 shares@ €13.58240.0013% mcap1.9% of flow
Common Stock
SEC:0001672659-26-000027:0·
US$5,9396,348 shares@ US$0.93560.0003% mcap0.8% of flow
Common Stock
SEC:0001933414-26-000058·
€5,9396,348 shares@ €0.93560.0003% mcap0.4% of flow
Common Stock
SEC:0001933414-26-000058:0·
US$5,7746,349 shares@ US$0.90940.0003% mcap0.7% of flow
Common Stock
SEC:0001672659-26-000011·
€5,7746,349 shares@ €0.90940.0003% mcap0.4% of flow
Common Stock
SEC:0001672659-26-000011:0·
US$30,9663,542 shares@ US$8.74260.0014% mcap4.0% of flow
Common Stock
SEC:0001672659-26-000006·
€30,9663,542 shares@ €8.74260.0014% mcap2.0% of flow
Common Stock
SEC:0001672659-26-000006:0·
US$29,7822,170 shares@ US$13.72460.0013% mcap3.8% of flow
Common Stock
SEC:0001672659-26-000004·
€29,7822,170 shares@ €13.72460.0013% mcap1.9% of flow
Common Stock
SEC:0001672659-26-000004:0·
US$9,24010,053 shares@ US$0.91910.0004% mcap1.2% of flow
Common Stock
SEC:0001672659-26-000002·
€9,24010,053 shares@ €0.91910.0004% mcap0.6% of flow
Common Stock
SEC:0001672659-26-000002:0·
US$382,93810,369 shares@ US$36.93110.017% mcap49.2% of flow
Common Stock
SEC:0001933414-25-000128·
€382,93810,369 shares@ €36.93110.017% mcap24.6% of flow
Common Stock
SEC:0001933414-25-000128:0·
US$283,8779,302 shares@ US$30.51790.013% mcap36.5% of flow
Common Stock
SEC:0001672659-25-000006·
€283,8779,302 shares@ €30.51790.013% mcap18.2% of flow
Common Stock
SEC:0001672659-25-000006:0·
16 of 16 declarations
About Rodman David Malcom
Rodman David Malcom is the Chief Medical Officer of Mineralys Therapeutics, Inc. He oversees the company's medical and clinical initiatives.
